Viral persistence in colorectal cancer cells infected by Newcastle disease virus

Suet-Lin Chia, Khatijah Yusoff, Norazizah Shafee1

  • 1Department of Microbiology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, Serdang 43400, Malaysia. nshafee@upm.edu.my.

Virology Journal
|June 3, 2014
PubMed
Abstract

Insights

Newcastle disease virus (NDV) can establish persistent infections in cancer cells, leading to treatment resistance. This finding is crucial for optimizing NDV virotherapy strategies in clinical settings.

Area of Science:

  • Oncology
  • Virology
  • Cancer Therapeutics

Background:

  • Newcastle disease virus (NDV) is a promising candidate for cancer virotherapy.
  • Clinical studies have shown promising responses to NDV treatment.
  • The potential for NDV to establish persistent infections in cancer cells remains unexplored.

Purpose of the Study:

  • To investigate the development of persistent Newcastle disease virus (NDV) infection in cancer cells.
  • To determine if persistent NDV infection impacts cancer cell susceptibility to viral killing.

Main Methods:

  • Infection of colorectal cancer cell lines with NDV.
  • Observation of adventitious persistent infection in SW480 cells.
  • Re-infection experiments to assess viral resistance in persistently infected cells.

Main Results:

  • A persistent NDV infection was observed in SW480 cells, designated SW480P.
  • SW480P cells demonstrated resistance to NDV-induced cell killing.
  • Persistently infected SW480P cells retained the NDV genome and produced progeny with reduced plaque-forming ability.

Conclusions:

  • Newcastle disease virus (NDV) can establish persistent infections in cancer cells.
  • Persistent NDV infection can lead to cancer cell resistance to virotherapy.
  • Consideration of persistent infection is essential for effective clinical application of NDV.

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.6K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

No description available
5.9K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
7.2K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

No description available
3.0K
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
50.5K
Viral Recombination00:57

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
25.6K